By examining the expression levels of immunosuppressive cytokines in the IGF2BP-H and IGF2BP-L groups, we found that VEGFA expression was significantly higher in the IGF2BP-H group in both HNSCC and PDAC (Fig. 5D). The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.